十二指肠壅滞症 中国就医指南

Superior Mesenteric Artery Syndrome (SMAS) is a rare but potentially life-threatening gastrointestinal disorder characterized by compression of the third portion of the duodenum between the superior mesenteric artery (SMA) and the abdominal aorta. This anatomical entrapment leads to partial or complete duodenal obstruction, resulting in postprandial epigastric pain, early satiety, nausea, vomiting (often bilious), weight loss, and malnutrition. Pathophysiologically, SMAS arises from a reduction in the aortomesenteric angle (normally 38–65°) and distance (typically 10–28 mm), most commonly due to rapid, significant loss of mesenteric fat—especially retroperitoneal and prevertebral fat—which normally cushions and supports the duodenum. Contributing factors include severe weight loss (e.g., following bariatric surgery, anorexia nervosa, major trauma, burns, or chronic illness), spinal deformities (e.g., scoliosis correction or lordosis), prolonged bed rest, and anatomical variants such as a low-lying SMA origin or hypermobility of the duodenum. Epidemiologically, SMAS is exceedingly rare, with an estimated incidence of fewer than 0.1–0.3% among patients undergoing upper GI imaging for suspected obstruction; it predominantly affects young adults (ages 20–40), with a slight female predominance (F:M ≈ 3:2), likely reflecting higher rates of intentional or pathological weight loss in this demographic. Risk factors extend beyond acute weight loss to include eating disorders, cancer cachexia, inflammatory bowel disease flares, prolonged nasogastric tube use, and recent spinal surgery. Importantly, SMAS is frequently misdiagnosed—as functional dyspepsia, gastroparesis, or psychiatric illness—leading to delays in management that exacerbate nutritional decline and psychological distress. Quality of life is profoundly impaired: patients report chronic pain, social withdrawal due to meal-related anxiety, depression, fatigue, and occupational disability. Without timely intervention, complications may include severe dehydration, electrolyte imbalances, gastric dilation, aspiration pneumonia, and even duodenal perforation. Early recognition hinges on high clinical suspicion in at-risk individuals, supported by diagnostic imaging—particularly contrast-enhanced CT angiography or upper GI series demonstrating the classic 'corkscrew' duodenal narrowing and reduced aortomesenteric angle (<25°) and distance (<8 mm). Multidisciplinary care involving gastroenterology, nutrition support, psychology, and occasionally vascular or general surgery is essential for optimal outcomes.

# 十二指肠壅滞症治疗方案与费用明细（消化内科）

一、非手术保守治疗（适用于轻中度、无肠梗阻、无严重营养不良者）

• •药物治疗：促胃肠动力药（多潘立酮/莫沙必利）、抑酸剂（艾司奥美拉唑）、营养支持（维生素B12、肠内营养粉）；费用：800–3,500元/疗程（4–12周）
• •饮食与体位疗法：低脂少渣饮食+餐后左侧卧位/膝胸位；免费或指导费≤200元
• •必要检查：上消化道造影（300–600元）、胃镜+十二指肠球部动态观察（800–1,500元）、腹部超声（200–400元）

二、手术与介入治疗（适用于保守无效、反复呕吐、体重下降＞10%、影像证实机械性压迫者）

• •腹腔镜十二指肠空肠吻合术（金标准）：创伤小、恢复快；术前检查（CT增强+心肺功能评估）2,200–3,800元；手术总费用（含麻醉、住院7–10天）45,000–78,000元
• •经内镜十二指肠支架置入术（姑息/高龄/手术禁忌者）：短期缓解；费用32,000–55,000元（含支架耗材）

三、复杂/并发症/晚期方案

• •合并重度营养不良（白蛋白＜30g/L）：需TPN支持+多学科营养干预；月均费用18,000–35,000元
• •粘连性肠梗阻复发或术后粘连加重：二次腹腔镜松解+防粘连膜应用；费用62,000–95,000元

方案快速选择指南

✅ 预算有限/初发轻症：首选药物+饮食管理（总费用≤4,000元） ✅ 中青年/症状顽固：腹腔镜吻合术（性价比最优，根治率＞90%） ✅ 高龄/合并心肺疾病：内镜支架或优化保守治疗，避免急诊手术风险